Auro Laboratories Ltd.
| BSE: 530233 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE292C01011 |
| BSE 13:23 | 16 May | 92.40 |
-3.95 (-4.10%) |
OPEN
96.75 |
HIGH
96.75 |
LOW
90.70 |
| NSE 05:30 | 01 Jan | Auro Laboratories Ltd |
| OPEN | 96.75 |
| PREVIOUS CLOSE | 96.35 |
| VOLUME | 2700 |
| 52-Week high | 195.00 |
| 52-Week low | 87.00 |
| P/E | 14.74 |
| Mkt Cap.(Rs cr) | 58 |
| Buy Price | 91.05 |
| Buy Qty | 9.00 |
| Sell Price | 92.40 |
| Sell Qty | 3.00 |
Auro Laboratories Ltd. (AUROLABS) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 549.90 | -12.25 | -2.18 | 3112.91 |
| Cipla | 931.35 | -1.50 | -0.16 | 2468.28 |
| Dr Reddy's Labs | 3872.10 | -51.40 | -1.31 | 2186.40 |
| Sun Pharma.Inds. | 883.90 | 1.80 | 0.20 | 2139.70 |
| Divi's Lab. | 4234.00 | -49.75 | -1.16 | 1954.72 |
| Alkem Lab | 2910.20 | 7.20 | 0.25 | 1685.08 |
| Glenmark Pharma. | 391.25 | -2.80 | -0.71 | 1649.45 |
| Zydus Lifesci. | 344.80 | 4.10 | 1.20 | 1476.20 |
| Lupin | 682.50 | -13.80 | -1.98 | 1258.62 |
| Alembic Pharma | 743.85 | 2.40 | 0.32 | 1175.39 |
| Ipca Labs. | 985.30 | 10.35 | 1.06 | 1140.77 |
| Torrent Pharma. | 2585.00 | 3.65 | 0.14 | 1137.85 |
| Gland Pharma | 3090.15 | 94.75 | 3.16 | 997.01 |
| Laurus Labs | 534.40 | -4.05 | -0.75 | 956.11 |
| Sanofi India | 6624.15 | -124.35 | -1.84 | 944.40 |
| Abbott India | 16402.60 | -139.80 | -0.85 | 690.69 |
| Ajanta Pharma | 1699.80 | -11.25 | -0.66 | 675.64 |
| Wockhardt | 235.95 | 1.45 | 0.62 | 593.29 |
| Granules India | 240.95 | 1.70 | 0.71 | 552.78 |
| Pfizer | 4210.85 | -41.85 | -0.98 | 497.61 |
Quick Links for Auro Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
